Supreme Court Affirms Amgen Patents’ Invalidity in Closely Watched Enablement Case - Life Sciences Perspectives Supreme Court Affirms Amgen Patents’ ...
Proposed USPTO Fee Changes Will Make It Much More Expensive to Patent and to Challenge Patents on Therapeutics. You Have ...
Google DeepMind has wielded its revolutionary protein-structure-prediction AI in the hunt for genetic mutations that cause disease. A new tool...
Read moreOn September 12, ufologist and journalist Jaime Maussan presented what he claimed to be evidence of alien life to the...
Read moreA set of mysterious 'hoofprints' on the seafloor off the coast of New Zealand are not actually the work of...
Read moreWhat is the moon made of? How do you tie a tie? Why do we dream? The answers to our questions...
Read more
© Life Sciences News Hubb All rights reserved.
Use of these names, logos, and brands does not imply endorsement unless specified. By using this site, you agree to the Privacy Policy and Terms & Conditions.
